HealthcareServices

Minimally Invasive Treatment Of Lung Cancer Market Expansion Outlook: $4.78 Billion by 2029 Forecast

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Minimally Invasive Treatment Of Lung Cancer Market By 2029?

The minimally invasive treatment of lung cancer market has experienced robust expansion in recent years. This market is projected to expand from $3.06 billion in 2024 to $3.35 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 9.7%. Historically, this growth has been fueled by factors such as the increasing incidence of lung cancer, greater understanding of minimally invasive techniques, an expanding older demographic, the implementation of early detection strategies, and improvements in healthcare infrastructure.

The minimally invasive treatment of lung cancer market is expected to witness robust expansion in the upcoming years. It is projected to reach $4.78 billion by 2029, achieving a compound annual growth rate (CAGR) of 9.3%. The growth during the forecast period can be attributed to an increasing demand for outpatient procedures, greater investment in specialized lung cancer centers, broader availability of minimally invasive treatment options, government initiatives promoting advanced healthcare, and a focus on reducing postoperative complications. Significant trends anticipated in the forecast period include technological advancements in surgical instruments, innovations in patient monitoring systems, the development of precision therapy techniques, ongoing research and development in less invasive interventions, and the integration of artificial intelligence for treatment planning.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27349&type=smp

Which Drivers Are Impacting The Minimally Invasive Treatment Of Lung Cancer Market?

The rising occurrence of lung cancer is projected to boost the expansion of the minimally invasive treatment of lung cancer market moving ahead. This condition is defined as a form of cancer that begins in the lungs and involves uncontrolled cellular proliferation. A significant factor contributing to the increase in lung cancer cases is the rise in tobacco smoking, which enhances the probability of unregulated cell multiplication and tumor development. Minimally invasive treatment offers advantages to lung cancer sufferers by precisely targeting, extracting, or eliminating tumors using small cuts or probes guided by imaging, thereby shortening recovery periods, reducing harm to healthy lung tissue, decreasing complication risks, and enabling quicker return to daily routines. As an illustration, in June 2025, data from the Centers for Disease Control and Prevention, a US-based government agency, revealed that in 2022, the United States documented 218,893 new diagnoses of lung cancer, resulting in 131,584 fatalities nationwide. Consequently, the expanding occurrence of lung cancer is a key factor propelling the advancement of the minimally invasive treatment of lung cancer market.

How Is The Minimally Invasive Treatment Of Lung Cancer Market Segmented?

The minimally invasive treatment of lung cancer market covered in this report is segmented

1) By Type: Lung Tumor Ablation, Lung Tumor Embolization

2) By Stage: Stage I, Stage II, Stage III, Stage IV

3) By Age Group: Under 30 Years, 31 To 45 Years, 46 To 60 Years

4) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research Institutions

Subsegments:

1) By Lung Tumor Ablation: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation

2) By Lung Tumor Embolization: Bronchial Artery Embolization, Pulmonary Artery Embolization, Chemoembolization, Radioembolization

What Are The Major Trends Driving The Growth Of The Minimally Invasive Treatment Of Lung Cancer Market?

Leading companies in the minimally invasive treatment of the lung cancer market are concentrating on developing advanced systems, such as fluoroscopic navigation platforms, to enhance accuracy and enable targeted, localized lung treatment. Fluoroscopic navigation platforms are medical imaging systems that integrate real-time fluoroscopy with navigation technology to precisely guide instruments to specific lung areas, facilitating minimally invasive biopsy and treatment of hard-to-reach lesions while reducing complications. For instance, in July 2022, Medtronic plc, an Ireland-based medical technology company, announced the world’s first endoluminal lung ablation procedure using the ILLUMISITE. This minimally invasive procedure, performed by physicians in Hong Kong, utilized the ILLUMISITE platform to accurately navigate through a patient’s lungs via a customized virtual pathway based on their CT scan. The platform’s navigation catheter helped guide the bronchoscope to the lung lesion, where a specialized ablation catheter delivered targeted treatment. This innovation represents a significant advancement in lung mass diagnosis and treatment, combining precise navigation with localized ablation technology.

Which Major Industry Participants Are Leading The Minimally Invasive Treatment Of Lung Cancer Market Growth?

Major companies operating in the minimally invasive treatment of lung cancer market are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Weill Cornell Medicine, Accuray Incorporated, Richard Wolf GmbH, AngioDynamics Inc., CMR Surgical Ltd., Biodesix Inc., Guangzhou Geyi Medical Instrument Co. Ltd., Quantum Surgical SA, Scanlan International Inc., RZ Medizintechnik GmbH & Co. KG, August Reuchlen GmbH, SBH Surgical GmbH & Co. KG, Geister Medizintechnik GmbH.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-treatment-of-lung-cancer-global-market-report

How Is Minimally Invasive Treatment Of Lung Cancer Market Demand Varying Across Different Regions?

North America was the largest region in the minimally invasive treatment of lung cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive treatment of lung cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Minimally Invasive Treatment Of Lung Cancer Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27349&type=smp

Browse Through More Reports Similar to the Global Minimally Invasive Treatment Of Lung Cancer Market 2025, By The Business Research Company

Credit Bureaus Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/credit-bureaus-global-market-report

Consumer Credit Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/consumer-credit-global-market-report

Credit Card Issuance Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/credit-card-issuance-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795